DE602004004541D1 - Myokard-stimulation - Google Patents

Myokard-stimulation

Info

Publication number
DE602004004541D1
DE602004004541D1 DE602004004541T DE602004004541T DE602004004541D1 DE 602004004541 D1 DE602004004541 D1 DE 602004004541D1 DE 602004004541 T DE602004004541 T DE 602004004541T DE 602004004541 T DE602004004541 T DE 602004004541T DE 602004004541 D1 DE602004004541 D1 DE 602004004541D1
Authority
DE
Germany
Prior art keywords
cells
transplanted
biological material
heart
directed
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
DE602004004541T
Other languages
English (en)
Other versions
DE602004004541T2 (de
Inventor
Orhan Soykan
Maura G Donovan
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medtronic Inc
Original Assignee
Medtronic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtronic Inc filed Critical Medtronic Inc
Publication of DE602004004541D1 publication Critical patent/DE602004004541D1/de
Application granted granted Critical
Publication of DE602004004541T2 publication Critical patent/DE602004004541T2/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3839—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by the site of application in the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/38—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells
    • A61L27/3804—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix containing added animal cells characterised by specific cells or progenitors thereof, e.g. fibroblasts, connective tissue cells, kidney cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362—Heart stimulators
    • A61N1/3627—Heart stimulators for treating a mechanical deficiency of the heart, e.g. congestive heart failure or cardiomyopathy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362—Heart stimulators
    • A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362—Heart stimulators
    • A61N1/365—Heart stimulators controlled by a physiological parameter, e.g. heart potential
    • A61N1/368—Heart stimulators controlled by a physiological parameter, e.g. heart potential comprising more than one electrode co-operating with different heart regions
DE602004004541T 2003-07-28 2004-07-22 Myokard-stimulation Active DE602004004541T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US49065903P 2003-07-28 2003-07-28
US490659P 2003-07-28
PCT/US2004/023713 WO2005011808A1 (en) 2003-07-28 2004-07-22 Myocardial stimulation

Publications (2)

Publication Number Publication Date
DE602004004541D1 true DE602004004541D1 (en) 2007-03-15
DE602004004541T2 DE602004004541T2 (de) 2007-11-22

Family

ID=34115421

Family Applications (1)

Application Number Title Priority Date Filing Date
DE602004004541T Active DE602004004541T2 (de) 2003-07-28 2004-07-22 Myokard-stimulation

Country Status (7)

Country Link
US (1) US7349740B2 (de)
EP (2) EP1651310B1 (de)
AT (1) ATE352346T1 (de)
CA (1) CA2533717A1 (de)
DE (1) DE602004004541T2 (de)
ES (1) ES2279445T3 (de)
WO (1) WO2005011808A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7765001B2 (en) 2005-08-31 2010-07-27 Ebr Systems, Inc. Methods and systems for heart failure prevention and treatments using ultrasound and leadless implantable devices
WO2006044589A2 (en) * 2004-10-13 2006-04-27 Medtronic, Inc. Cellular and genetic intervention to treat ventricular tachycardia
EP1833553B1 (de) 2004-12-21 2015-11-18 EBR Systems, Inc. Implantierbare wandler
US7558631B2 (en) * 2004-12-21 2009-07-07 Ebr Systems, Inc. Leadless tissue stimulation systems and methods
JP5111116B2 (ja) * 2004-12-21 2012-12-26 イービーアール システムズ， インコーポレイテッド ペーシングおよび不整脈処置のためのリード線のない心臓システム
GB0505940D0 (en) * 2005-03-23 2005-04-27 Bmr Res & Dev Ltd Muscle stimulation apparatus and method
US7647122B2 (en) * 2005-07-26 2010-01-12 Medtronic, Inc. Surgical needle driver
US20070027512A1 (en) * 2005-07-26 2007-02-01 Medtronic, Inc. Stimulation electrode array
US7702392B2 (en) * 2005-09-12 2010-04-20 Ebr Systems, Inc. Methods and apparatus for determining cardiac stimulation sites using hemodynamic data
US7844331B2 (en) * 2005-12-20 2010-11-30 Cardiac Pacemakers, Inc. Method and apparatus for controlling anti-tachyarrhythmia pacing using hemodynamic sensor
US7792584B2 (en) * 2006-04-25 2010-09-07 Medtronic, Inc. System and method for characterization of atrial wall using digital signal processing
US20080008609A1 (en) * 2006-07-06 2008-01-10 Pate Thomas D Positive displacement pump system and method
US20100268333A1 (en) * 2009-04-16 2010-10-21 Gohean Jeffrey R System and method for controlling pump
EP2079516A2 (de) * 2006-09-29 2009-07-22 Second Sight Medical Products, Inc. Verfahren zur messung der stabilen und reproduzierbaren elektroden-gewebe-impedanz
US8588904B2 (en) * 2006-10-13 2013-11-19 Lifescience Solutions Llc Pacemaker
US7787950B1 (en) * 2006-11-03 2010-08-31 Pacesetter, Inc. Techniques for delivery of stem cell and related therapies to treat cardiac conditions
US7930022B2 (en) 2007-05-07 2011-04-19 Cardiac Pacemakers, Inc. System and method to determine hemodynamic tolerability
US8224443B2 (en) * 2007-05-08 2012-07-17 Cardiac Pacemakers, Inc. Method for controlling pacemaker therapy
US8718773B2 (en) 2007-05-23 2014-05-06 Ebr Systems, Inc. Optimizing energy transmission in a leadless tissue stimulation system
EP2265166B1 (de) 2008-03-25 2020-08-05 EBR Systems, Inc. Vorübergehende elektrodenverbindung für drahtlose schrittmachersysteme
JP5209787B2 (ja) 2008-06-19 2013-06-12 カーディアック ペースメイカーズ， インコーポレイテッド 血流力学耐容性分析器を有する心調律管理システム
EP2349469B1 (de) * 2008-11-07 2018-03-21 MUSC Foundation For Research Development Vorrichtungen zur behandlung von myokarderkrankungen
US8386040B2 (en) * 2009-04-16 2013-02-26 The Board Of Regents Of The University Of Texas Systems System and method for pump variable stroke
US8366401B2 (en) * 2009-04-16 2013-02-05 The Board Of Regents Of The University Of Texas Systems Positive displacement pump system and method with rotating valve
US8167593B2 (en) * 2009-04-16 2012-05-01 The Board Of Regents Of The University Of Texas System System and method for pump with deformable bearing surface

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6090776A (en) * 1991-03-11 2000-07-18 Creative Bio Molecules, Inc. Morphogen treatment of organ implants
US6077823A (en) * 1991-03-11 2000-06-20 Creative Biomolecules, Inc. Method for reducing tissue damage associated with ischemia-reperfusion or hypoxia injury
AU718073B2 (en) * 1996-03-28 2000-04-06 Medtronic, Inc. Detection of pressure waves transmitted through catheter/lead body
US6151525A (en) * 1997-11-07 2000-11-21 Medtronic, Inc. Method and system for myocardial identifier repair
US6233487B1 (en) * 1999-06-08 2001-05-15 Impulse Dynamics N.V. Apparatus and method for setting the parameters of an alert window used for timing the delivery of ETC signals to a heart under varying cardiac conditions
WO2002008387A1 (fr) * 2000-07-21 2002-01-31 Cellseed Inc. Feuille cellulaire du type muscle cardiaque, construction tridimensionnelle, tissu du type muscle cardiaque et procede de production associe
US7067317B2 (en) * 2000-12-07 2006-06-27 Sangamo Biosciences, Inc. Regulation of angiogenesis with zinc finger proteins
JP2004537260A (ja) * 2000-12-07 2004-12-16 サンガモ バイオサイエンシーズ， インコーポレイテッド ジンクフィンガータンパク質による血管新生の調節
WO2002049714A2 (en) * 2000-12-21 2002-06-27 Medtronic, Inc. Electrically responsive promoter system
US6738667B2 (en) * 2000-12-28 2004-05-18 Medtronic, Inc. Implantable medical device for treating cardiac mechanical dysfunction by electrical stimulation
WO2002072191A2 (en) * 2001-03-12 2002-09-19 Chachques Juan C Method of providing a dynamic cellular cardiac support

Also Published As

Publication number Publication date
EP1776969A3 (de) 2007-08-01
CA2533717A1 (en) 2005-02-10
DE602004004541T2 (de) 2007-11-22
US20050043766A1 (en) 2005-02-24
EP1651310B1 (de) 2007-01-24
ES2279445T3 (es) 2007-08-16
EP1776969A2 (de) 2007-04-25
ATE352346T1 (de) 2007-02-15
WO2005011808A1 (en) 2005-02-10
US7349740B2 (en) 2008-03-25
EP1651310A1 (de) 2006-05-03

Similar Documents

Publication Publication Date Title
DE602004004541D1 (en) Myokard-stimulation
US20020124855A1 (en) Method of providing a dynamic cellular cardiac support
US20050002912A1 (en) Method of providing a dynamic cellular cardiac support
DE602006015599D1 (de) Ng mit kardioprotektivem effekt
US9533085B2 (en) Intracardiac implant—total artificial heart
EP1435977A4 (de) Herztransplantation von stammzellen zur behandlung von herzinsuffizienz
WO2006125120A3 (en) Body lumen shaping device with cardiac leads
WO2006012038A3 (en) Selectively adjustable cardiac valve implants
DE69118325D1 (de) Einrichtung zur Verhinderung von Herzfunktionstörungen
WO2006044467A3 (en) Method and device for percutaneous left ventricular reconstruction
WO2004030706A3 (en) Bioactive implants
WO2005007233A3 (en) Application of electrical stimulation for functional tissue engineering in vitro and in vivo
JP2005230566A5 (de)
WO2003041796A3 (en) Adjustable cardiac resynchronization
WO2006002306A3 (en) Implantable chamber for biological induction or enhancement of muscle contraction
MX2010001353A (es) Poblacion de celulas madre adultas derivadas de tejido adiposo cardiaco y su uso en regeneracion cardiaca.
US20060149184A1 (en) Myocardial stimulation
WO2006017567A3 (en) Customizing stem cell-derived cardiomyocytes for transplantation
WO2001022978A3 (en) Autologous marrow stem cell (msc) transplantation for myocardial regeneration
EP1581241A4 (de) Stimulation von vaskularisierung mit vegf-b
WO2004015091A3 (en) Preparation of type ii pneumocytes from stem cells
CN109420254A (zh) 一种基于单电极实现crt治疗的心脏起搏器及心脏起搏系统
WO2001048164A3 (en) Modified adenylylcyclase type vi useful in gene therapy for congestive heart failure
RU2007132606A (ru) Способ оптимизации частотно-адаптивной атриовентрикулярной задержки в двухкамерных электрокардиостимуляторах
Salmons et al. Cardiomyoplasty reviewed: Lessons from the past, prospects for the future

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8328 Change in the person/name/address of the agent

Representative=s name: KUDLEK & GRUNERT PATENTANWAELTE PARTNERSCHAFT, 803